Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | NTLAIntellia Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $67.67M |
| Revenue, yoy | +16.9% |
| Net income | $412.69M |
| Net income, yoy | +20.5% |
| Net margin | -609.9% |
| Free cash flow | $395.87M |
| FCF margin | -585.0% |
| EPS, diluted | $3.81 |
Add another company.